Stock Hero Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 4/27/2015 12:50:07 AM - Followers: 578 - Board type: Free - Posts Today: 10

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Cellceutix closes $30M stock purchase agreement 04/01/2015 08:59:20 AM
CTIX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 03/31/2015 04:19:17 PM
CTIX News: Independent Research Initiates Analyst Coverage on Inventergy Global, Inc. (NASDAQ: INVT) with $1.20 Price Target 03/12/2015 08:00:00 AM
CTIX News: Quarterly Report (10-q) 02/09/2015 12:38:38 PM
CTIX News: NEW CONCEPT LAUNCHES TODAY FOR MICRO-CAP STOCK TRADERS. RECEIVE PAID PRE-PROMO STOCK ALERTS FOR FREE. 02/09/2015 07:00:00 AM
PostSubject
#98445  Sticky Note Kevetrin and Brilacidin Abstract info... BooDog 04/20/15 05:49:55 PM
#97761  Sticky Note There was actually quite a bit packed into BigKahuna 04/14/15 02:18:26 PM
#95145  Sticky Note $CTIX Lead drug info, News, SEC filings, FDA KarinCA 03/21/15 12:39:45 PM
#92697  Sticky Note upcoming catalysts slcimmuno 02/26/15 09:18:08 AM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#99320   Form 8A12B-uplist announcement number 1 noretreat 04/27/15 06:32:20 AM
#99319   Thanks... Here's the link for those that haven't KarinCA 04/27/15 12:50:07 AM
#99318   Yep, that's my read, too. Dr. Menon's territory. biodoc 04/27/15 12:37:36 AM
#99317   The Klebsiella and Ecoli data show excellent MIC's farrell90 04/27/15 12:30:51 AM
#99316   Thanks KarinCA. Dr. Menon has a great library biodoc 04/27/15 12:24:15 AM
#99315   No problem. I'm hoping you share your thoughts. biodoc 04/27/15 12:15:44 AM
#99314   Click on download abstract: (different from what KarinCA 04/27/15 12:12:06 AM
#99313   Thanks I have been out all day. Trying farrell90 04/27/15 12:10:00 AM
#99311   farrell90, you can access presentation slides from the biodoc 04/27/15 12:02:15 AM
#99310   I believe ToInfinity was looking for a single biodoc 04/26/15 11:59:59 PM
#99308   Thank you , maybe you could inform me WHcraftsman 04/26/15 11:59:24 PM
#99307   CTIX Defensin 1278 was noted to have Gram farrell90 04/26/15 11:41:05 PM
#99306   I'm with Miles in downright expecting a wee nerby 04/26/15 10:53:43 PM
#99305   Ha I'm not that knowledgable either but long brucethepotter 04/26/15 10:52:27 PM
#99304   Well I think it is excellent at your brucethepotter 04/26/15 10:50:28 PM
#99303   I sleep well with my money here though WHcraftsman 04/26/15 10:50:10 PM
#99302   You may have missed this because the update BigKahuna 04/26/15 10:46:37 PM
#99301   I just came into a bit of money WHcraftsman 04/26/15 10:45:02 PM
#99300   25! I wish I had been smart enough brucethepotter 04/26/15 10:42:59 PM
#99299   I know it's ridiculous reading posts lately it's WHcraftsman 04/26/15 10:40:12 PM
#99298   Use the iggy button. It's like turning off TheDane 04/26/15 09:24:29 PM
#99297   You are fixated solely on today's price and morecoffee 04/26/15 09:22:31 PM
#99296   It's the stock market or a company making KarinCA 04/26/15 09:20:54 PM
#99295   It's the disease of focusing on the short frrol 04/26/15 09:11:37 PM
#99294   No. However, if so, it will come back. KarinCA 04/26/15 09:05:39 PM
#99292   Doubt it / Many investors seemingly losing a slcimmuno 04/26/15 09:04:44 PM
#99290   Expect more good news this week regarding Cellceutix georgejjl 04/26/15 08:44:18 PM
#99289   Does anyone think by Actavis announcing topline Phase fam401 04/26/15 08:42:58 PM
#99287   To infinity- yes, Pseudomonas coverage is very important. biodoc 04/26/15 08:37:25 PM
#99286   I don’t always defend/agree with Leo. KarinCA 04/26/15 08:35:43 PM
#99285   Let's see what Leo does to bring in BobbyKIrk 04/26/15 08:30:56 PM
#99279   The majority of posters aren't physicians. Physicians KarinCA 04/26/15 07:54:28 PM
#99278   I did not say it was not a To infinity and beyond! 04/26/15 07:48:09 PM
#99277   More on why HDP-Ms may be a good slcimmuno 04/26/15 07:26:46 PM
#99276   How often do you hear discussions of the To infinity and beyond! 04/26/15 07:24:51 PM
#99275   I was just messin'. I like your scottsmith 04/26/15 07:15:48 PM
#99274   Yes, Amatuer17, I agree- I should have directed biodoc 04/26/15 07:15:34 PM
#99273   Biodov - thanks and yes I agree with Amatuer17 04/26/15 07:09:18 PM
#99272   Double posted. My apologies. btw, lack of Pseudomonas biodoc 04/26/15 06:56:31 PM
#99271   Perspective: CC-1807 appears highly effective against carbapenem-resistant biodoc 04/26/15 06:56:30 PM
#99269   wowzers, I wrote today off. :-) A toast BooDog 04/26/15 06:09:03 PM
#99267   TIAB - yes one can look at the Amatuer17 04/26/15 05:49:30 PM
#99266   Under 2 dollars or over 4.00. That's all BobbyKIrk 04/26/15 05:45:28 PM
#99265   best news I heard in awhile! JUST 10-11-12 04/26/15 05:43:57 PM
#99264   Sigh. Why do YOU think the speaker To infinity and beyond! 04/26/15 05:43:49 PM
#99263   Not changed my tune one iota. 1400 04/26/15 05:38:45 PM
#99262   You guys are to funny ,you change your BobbyKIrk 04/26/15 05:35:49 PM
#99261   You don't speak for me BobbyKirk I have 1400 04/26/15 05:28:19 PM
#99260   Is this another one of your quick expert 1400 04/26/15 05:21:19 PM
#99259   Thanks, links added to the footnotes of the TOB 04/26/15 05:14:24 PM
PostSubject